GSK plc (GSK)

GSK Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	78,504	68,786	75,295	70,343	108,945	91,204
Market Cap Growth	-2.25%	-8.64%	7.04%	-35.43%	19.45%	-21.79%
Enterprise Value	96,549	84,175	92,667	87,835	147,418	132,464
Last Close Price	39.13	33.07	34.89	31.82	38.97	30.77
PE Ratio	34.39	21.34	12.00	3.90	18.35	11.62
PS Ratio	1.81	1.75	1.95	1.99	3.26	2.74
PB Ratio	3.99	4.20	4.62	5.78	3.77	3.21
P/FCF Ratio	9.03	10.66	10.84	9.33	11.49	8.96
P/OCF Ratio	7.42	8.38	8.73	7.89	10.12	7.91
EV/Sales Ratio	2.23	2.14	2.40	2.49	4.41	3.98
EV/EBITDA Ratio	7.58	8.09	7.06	7.84	14.04	11.98
EV/EBIT Ratio	11.07	10.87	8.66	9.96	19.32	16.04
EV/FCF Ratio	11.11	13.04	13.34	11.65	15.55	13.02
Debt / Equity Ratio	1.21	1.30	1.41	2.08	1.13	1.31
Debt / EBITDA Ratio	1.83	1.99	1.72	2.22	3.12	3.35
Debt / FCF Ratio	2.71	3.30	3.30	3.35	3.45	3.64
Asset Turnover	0.54	0.53	0.51	0.42	0.31	0.30
Inventory Turnover	1.50	1.58	1.58	1.72	1.36	1.23
Quick Ratio	0.56	0.50	0.60	0.66	0.53	0.62
Current Ratio	0.87	0.78	0.89	0.91	0.79	0.91
Return on Equity (ROE)	28.33%	22.80%	46.38%	31.31%	16.68%	26.06%
Return on Assets (ROA)	6.78%	6.53%	8.82%	6.57%	4.41%	4.72%
Return on Capital (ROIC)	12.75%	12.70%	16.97%	11.95%	7.53%	7.81%
Return on Capital Employed (ROCE)	16.40%	16.40%	22.10%	19.60%	10.20%	10.40%
Earnings Yield	5.97%	4.69%	8.34%	25.62%	5.45%	8.61%
FCF Yield	11.07%	9.38%	9.23%	10.72%	8.70%	11.15%
Dividend Yield	4.06%	2.31%	2.12%	2.32%	3.48%	4.44%
Payout Ratio	139.76%	94.91%	45.60%	23.18%	91.20%	69.18%
Buyback Yield / Dilution	-0.48%	-0.75%	-0.66%	-0.79%	-0.55%	-0.43%
Total Shareholder Return	3.59%	1.55%	1.46%	1.53%	2.93%	4.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q